Skip to main content

People

US bill proposes greater OTC regulation

Legislation to bring over-the-counter (OTC) derivatives under US federal regulation has been introduced to the US House of Representatives. Peter DeFazio, representative for Oregon (Democrat), introduced a bill named HR 4038 that proposes combining the…

CBOT appoints new head of business and product development

The Chicago Board of Trade (CBOT) has named Martin Reiner senior vice-president in charges of sales, marketing and product development. The appointment is important, as the CBOT and rival Chicago-based derivatives exchanges, the Chicago Board Options…

Staying clear of equities

Peter Brain has enjoyed success with the Stellar High Yield Hedge Fund by mixing different asset classes and a low correlation to equities

The Specialists

Finding experienced staff in such a young industry can be extremely difficult and so headhunting firms are starting to do big business filling this gap

Keeping it in the family

Beverly Chandler talks to Gailen Krug, chief investment officer and vice president of Waycrosse Inc about the company's method of managing money in a family office.

ABN Amro adds to institutional forex sales

ABN Amro has made three new hires in institutional foreign exchange sales – part of its global financial markets business. All three report to Chicago-based Robert Rodman, ABN's global head of forex product sales to financial institutions and the public…

Merill Lynch hires for European derivatives sales

Merrill Lynch has made two new hires for its derivatives sales force in Europe. Robert Machin joins as a director of interest rate derivatives, and Konstantin Krebs joins as a senior vice-president, marketing credit derivatives, interest rate derivatives…

Merrill Lynch snags two from SG in Asia

Merrill Lynch (Asia Pacific) has snatched two derivatives specialists from SG Securities Global Equities, in a move to strengthen its position in the region's equity derivatives markets, according to the bank.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here